全球新冠疫情下科研伦理危机——行为表现、生成逻辑与治理路径

摘要
图/表
参考文献
相关文章 (1)

全文: PDF (1115 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要新冠疫情在全球蔓延,给科研伦理带来诸多新的危机:受试者临床试验和疫苗开发医学伦理危机、新冠疫情“短科学”伦理危机和偏离科研伦理标准多重风险危机。这些危机的生成逻辑具有多重性,新冠疫情不确定性及恐慌心理引发试验伦理危机,新冠疫情紧迫性促生不合规科研伦理风险,新冠疫情政治化引发重大医学科研偏移。对此,科研共同体应加强科研伦理危机全周期治理、科研区链域场治理、疫情相关科研伦理审查程序规范化治理,同时应强化新冠疫情相关科研本真的严谨性和科研价值的社会性。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	武学超
	李杰明

关键词 ：新冠疫情, 科研伦理危机, 行为表现, 生成逻辑, 治理路径

Abstract：The global spread of COVID-19 has brought about many new crises in scientific research ethics such as the medical ethics crisis of clinical trials and vaccine development in subjects,the“short science”ethics crisis of COVID-19 and the multiple risks of deviation from research ethics standards.The generation logic of these crises is multiple.The uncertainty and panic of the COVID-19 has led to the ethical crisis of the trials,the urgency of the COVID-19 promotes the ethical risk of non-compliant research,and the politicization of the COVID-19 has led to a major deviation of medical research.In this regard,research cmmunities should strenthen the full cycle governance of the scientific research ethics crisis,the chain field governance of the scientific research area and the governance of epidemic-related research ethical review process standardization,along with emphasis on the preciseness and the social value of the scientific research related to the COVID-19.

Key words： COVID-19 Ethical crisis of scientific research Performance Generation logic Governance path

收稿日期: 2022-05-25

PACS:

G301

基金资助:河南省哲学社会科学规划项目“开放科学视角下大学科研伦理危机及治理路径研究”(2021BJY016),河南省高等学校哲学社会科学应用研究重大项目“河南高校赋能重要人才中心建设研究”(2023-YYZD-09)。

作者简介: 武学超(1975—),男,河南南阳人,博士、教授,研究方向科技安全与伦理治理。

引用本文:

武学超, 李杰明. 全球新冠疫情下科研伦理危机——行为表现、生成逻辑与治理路径[J]. 中国科技论坛, 2023(3): 140-148.
Wu Xuechao, Li Jieming. Ethical Crisis of Scientific Research in the Global COVID-19:Performance,Generation Logic and Governance Paths. , 2023(3): 140-148.

链接本文:

http://www.zgkjlt.org.cn/CN/Y2023/I3/140

[1]ADRTANNA S,BEATA B.Social researchers' approaches to research ethics during the COVID-19 pandemic:an exploratory study[J].Journal of empirical research on human research ethics,2022;17(1/2):213-222.
[2]KHENG Y,KETAN S.Research ethics during a pandemic[J].International health,2021,13(4):374-375.
[3]DEPERGOLA P.Ethical guidelines for the treatment of patients with suspected or confirmed novel coronavirus disease[J].Journal of health ethics,2020,16(1):1-41.
[4]ANDREC K.Treating COVID-19:Off-label drug use,compassionate use,and randomized clinical trials during pandemics[J].JAMA,2020,323(19):1897-1898.
[5]ANNETTE R,MARC L.The ethics of continuing placebo in SARS-CoV-2 vaccine trials[J].Journal of the American medical association,2021,325(3):219-220.
[6]BIERER B,WHITE S.Ethical challenges in clinical research during the COVID-19 pandemic[J].Bioethical inquiry 2020,17(4):717-722.
[7]MIHAELA F.Some research ethics questions during the COVID-19 pandemics:what prospects for the future[J].Postmodern openings,2020,11(1):20-28.
[8]VICKI X,MARKUS L.The perfect moral storm:diverse ethical considerations in the COVID-19 pandemic[J].Asian bioethics review,2020,12(2),65-83.
[9]JULIAN S.Utilitarianism and the pandemic[J].Bioethics.2020,34(6):620-632.
[10]BBC.Covid-19:World's first human challenge trials to start in UK[EB/OL].(2021-12-28)[2022-02-17].https://www.bbc.com/news/health-56097088.
[11]ALBERTO G,SUNETRA G,CARL H.A focused protection vaccination strategy:why we should not target children with COVID-19 vaccination policies[J].Journal of medical ethics,2021,47(6):563-566.
[12]SMITH J,EZEKIEL E.Ethical conditions for accelerating COVID-19 vaccine research[J].Wellcome open research,2020,36(5):249-263.
[13]SIMON K.Research ethics in COVID-19:Long vs short science[EB/OL].(2022-01-11)[2022-06-22].https://committees.parliament.uk/writtenevidence/9536/pdf/.
[14]BARROGA E,MATANGUIHAN G J.Fundamental shifts in research,ethics and peer review in the era of the COVID-19 pandemic[J].Journal of Korean medical science.2020,35(45):395-403.
[15]BETHANY H,LAURA H.How COVID-19 has changed the culture of science[EB/OL].(2022-05-13)[2022-06-12].https://cen.acs.org/biological-chemistry/infectious-disease/How-COVID-19-has-changed-the-culture-of-science/99/i3.
[16]PANDOLFI S,VALDENASSI L.COVID-19 medical and pharmacological management in the European countries compared to Italy:an overview[J].International journal of environmental research and public health.2022,19(7):42-62.
[17]KUPFERSCHMIDT K,COHEN J.Race to find COVID-19 treatments accelerates[J].Science,2020,367(6485):1412-1413.
[18]RAYNAUD M,GOUTAUDIER V,LOUIS K.Impact of the COVID-19 pandemic on publication dynamics and non-COVID-19 research production[J].BMC medical research methodology,2021,21(1):255-267.
[19]BOMMIER C,STOEKLE H.-C.COVID-19:The urgent call for academic research in research ethics[J].Ethics,medicine and public health,2021(18):12-14.
[20]SEYFERTH A V,WOOD S M.Representation of ethics in COVID-19 research:a systematic review[J].Plastic and reconstructive surgery,2022,149(5):1237-1244.
[21]SOLBAKK J H,BENTZEN H B.Back to what? The role of research ethics in pandemic times[J].Medical health care and philosophy,2021,24(5):3-20.
[22]LONDON A J,KIMMELMAN J.Against pandemic research exceptionalism[J].Science.2020,368(6490):476-477.
[23]CRIVELLO G,FAVARA M.COVID-19 and the ethics of disruption:Current dilemmas facing longitudinal research in low-and middle-income countries[J].Methodological innovations,2021,14(1):1-5.
[24]LAURA D.A state of fear:how the UK government weaponised fear during the Covid-19 pandemic[M].London:Pinter & Martin Publishing,2021:23.
[25]World Health Organization.Guidance for research ethics committees for rapid review of research during public health emergencies[EB/OL].(2020-05-28)[2022-06-18].https://www.who.int/publications-detail-redirect/9789240006218.
[26]GARCIA G E,ANGULO B A,LECUONA O.Exploring COVID-19 research credibility among Spanish scientists[J].Current psychology.2022,23(2):1-12.
[27]LURIE N,SAVILLE M.Developing Covid-19 vaccines at pandemic speed[J].New England journal of medicine,2020,382(21):1969-1973.
[28]World Health Organization.Ethical standards for research during public health emergencies:distilling existing guidance to support COVID-19[R].Geneva:the WHO working group on ethics & COVID-19 policy brief,2020.
[29]CHATFIELD K,SCHROEDER D.Ethical research in the COVID-19 era demands care,solidarity and trustworthiness[J].Research ethics,2020,16(3/4):1-4.
[30]SISK B A,BALDWIN K.Ethical,regulatory,and practical barriers to COVID-19 research:a stakeholder-informed inventory of concerns[J].PLoS one.2022,17(3):1-23.
[31]CLARA C,CORINNE R.Ethical challenges in the COVID-19 research context:a toolkit for supporting analysis and resolution[J],Ethics & behavior,2021,31(1):60-75.
[32]SCHOPPER D,RAVINETTO R,SCHWARTZ L,et al.Research ethics governance in times of Ebola[J].Public health ethics,2017,10(1):49-61.
[33]Pan American Health Organization.Guidance and strategies to streamline ethics review and oversight of COVID-19-related research[R].Washington,D.C.:Pan American health organization working paper,2020.
[34]PALMERO A,CARRACEDO S.Governance frameworks for COVID-19 research ethics review and oversight in Latin America:an exploratory study[J].BMC medical ethics,2021,147(22):1-9.
[35]World Health Organization.Key criteria for the ethical acceptability of COVID-19 human challenge studies[EB/OL].(2020-05-03)[2022-03-16].https://www.who.int/publications/i/item/WHO-2019-nCoV-Ethics_criteria-2020.
[36]GAMAD N,MOHINDRA R.Some reflections on vaccine research ethics during COVID-19 pandemic[J].Postgraduate medical journal,2022,98(2):84-85.
[37]KAYE D K.Navigating ethical challenges of conducting randomized clinical trials on COVID-19[J].Philosophy,ethics,and humanities in medicine,2022,17(2):1-11.
[38]HALL J,GAVED M.Participatory research approaches in times of COVID-19:a narrative literature review[J].International journal of qualitative methods,2021,20(6):1-15.